4-ethoxy-2',4'-dimethylbiphenyl

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-ethoxy-2',4'-dimethylbiphenyl
• 英文别名: 1-(4-ethoxyphenyl)-2,4-dimethylbenzene
• 化学式: C₁₆H₁₈O
• 分子量: 226.318
• InChiKey: OJLSRCVIAHLALD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2,4-二甲基苯酚 、 alkaline earth salt of/the/ methylsulfuric acid 在 palladium diacetate 、 potassium phosphate 、 三乙胺 、 2-二环己基磷-2,4,6-三异丙基联苯 作用下， 以 二氯甲烷 、 叔丁醇 为溶剂， 反应 17.0h， 生成 4-ethoxy-2',4'-dimethylbiphenyl
  参考文献：
  名称：

  用于芳基芳烃磺酸酯的 Suzuki-Miyaura 和羰基烯醇酸酯偶联的第一个通用钯催化剂

  摘要：

  利用 XPhos、1 和 Pd(OAc)2 开发了钯催化的 Suzuki-Miyaura 和未活化芳基芳烃磺酸酯羰基烯醇化物偶联的第一种通用方法。这是非常有趣的，因为芳基甲苯磺酸酯和芳基苯磺酸酯比芳基三氟甲磺酸酯更容易处理且成本低得多。该催化剂体系在温和条件下实现了多种芳基、杂芳基和受阻极强的芳基硼酸与不同的甲苯磺酸芳基酯的偶联。在芳基芳烃磺酸酯的第一次羰基烯醇化物偶联中使用相同的催化剂。

  DOI：

  10.1021/ja036947t

文献信息

• [EN] 3,7-DIAZABICYCLO[3.3.1]NONANE AND 9-OXA-3,7-DIAZABICYCLO[3.3.1]NONANE DERIVATIVES<br/>[FR] DÉRIVÉS DE 3,7-DIAZABICYCLO[3.3.1]NONANE ET DE 9-OXA-3,7- DIAZABICYCLO[3.3.1]NONANE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2013050938A1

  公开（公告）日：2013-04-11

  The present invention relates to 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7- diazabicyclo[3.3.1 ]nonane derivatives of formula (I) wherein Ar1 and Ar2 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.

  本发明涉及式（I）的3,7-二氮杂双环[3.3.1]壬烷和9-氧-3,7-二氮杂双环[3.3.1]壬烷衍生物，其中Ar1和Ar2如描述中所述，其制备方法，其药学上可接受的盐，以及作为药物的用途，含有一种或多种式（I）化合物的药物组合物，特别是其用作促进睡眠受体拮抗剂。
• Norvaline Derivative and Method for Preparation Thereof
  申请人：Harada Naoyuki

  公开号：US20080076769A1

  公开（公告）日：2008-03-27

  Norvaline derivative of the formula [I] or pharmaceutically acceptable salt thereof, method for preparing the same, pharmaceutical composition containing the same, and use of said compound for inhibiting transporting activity of glycine transporter type 2 (GlyT2). [wherein X is —CH 2 —, —O—, —S— or single bond; Ar is optionally substituted aryl or lower cycloalkyl; n is 0 to 2; R 1 and R 2 are (i) each is hydrogen or lower alkyl; (ii) R 1 and R 2 are combined to form lower alkylene; or (iii) R 1 is hydrogen or lower alkyl and R 2 is combined with R 4 or R 6 to form lower alkylene; R 3 and R 4 are (i) each is hydrogen or lower alkyl; (ii) R 3 and R 4 are combined to form lower alkylene; or (iii) R 3 is hydrogen or lower alkyl and R 4 is combined with R 2 or R 6 to form lower alkylene; R is or —OR 7 ; R 5 and R 6 are (i) each is optionally substituted lower alkyl, or hydrogen; (ii) R 5 and R 6 are combined to form aliphatic 5- to 6-membered heterocyclic group; or (iii) R 5 is optionally substituted lower alkyl or hydrogen and R 6 is combined with R 2 or R 4 to form lower alkylene; R 7 is lower alkyl.

  Norvaline衍生物的化学式[I]或其药学上可接受的盐，制备方法，含有该化合物的药物组合物，以及用于抑制甘氨酸转运体2型（GlyT2）的转运活性的用途。[其中X为-CH2-，-O-，-S-或单键；Ar为可选取代芳基或较低的环烷基；n为0至2；R1和R2为（i）氢或较低的烷基；（ii）R1和R2结合形成较低的烷基；或（iii）R1为氢或较低的烷基，R2与R4或R6结合形成较低的烷基；R3和R4为（i）氢或较低的烷基；（ii）R3和R4结合形成较低的烷基；或（iii）R3为氢或较低的烷基，R4与R2或R6结合形成较低的烷基；R为-OH或-OR7；R5和R6为（i）可选取代的较低烷基或氢；（ii）R5和R6结合形成脂肪族5-至6-成员杂环基；或（iii）R5为可选取代的较低烷基或氢，R6与R2或R4结合形成较低的烷基；R7为较低烷基。
• NORVALINE DERIVATIVE AND METHOD FOR PREPARATION THEREOF
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP1846366B1

  公开（公告）日：2011-08-03
• US7718703B2
  申请人：——

  公开号：US7718703B2

  公开（公告）日：2010-05-18
• The First General Palladium Catalyst for the Suzuki−Miyaura and Carbonyl Enolate Coupling of Aryl Arenesulfonates
  作者：Hanh Nho Nguyen、Xiaohua Huang、Stephen L. Buchwald

  DOI：10.1021/ja036947t

  日期：2003.10.1

  for the palladium-catalyzed Suzuki-Miyaura and carbonyl enolate coupling of unactivated aryl arenesulfonates was developed utilizing XPhos, 1, and Pd(OAc)2. This is of significant interest because aryl tosylates and aryl benzenesulfonates are more easily handled and considerably less expensive than aryl triflates. This catalyst system effects the coupling of a variety of aryl, heteroaryl, and extremely

  利用 XPhos、1 和 Pd(OAc)2 开发了钯催化的 Suzuki-Miyaura 和未活化芳基芳烃磺酸酯羰基烯醇化物偶联的第一种通用方法。这是非常有趣的，因为芳基甲苯磺酸酯和芳基苯磺酸酯比芳基三氟甲磺酸酯更容易处理且成本低得多。该催化剂体系在温和条件下实现了多种芳基、杂芳基和受阻极强的芳基硼酸与不同的甲苯磺酸芳基酯的偶联。在芳基芳烃磺酸酯的第一次羰基烯醇化物偶联中使用相同的催化剂。